As used in this report, each of the terms "we," "us," "our," the "Company" and
"Simulations Plus" refers to Simulations Plus, Inc. and Cognigen Corporation,
unless otherwise stated or the context otherwise requires.
Simulations Plus, Inc., incorporated in 1996, is a premier developer of
groundbreaking drug discovery and development software for mechanistic modeling
and simulation. Our software is licensed to major pharmaceutical, biotechnology,
agrochemical, and food industry companies and to regulatory agencies worldwide
for use in the conduct of industry-based research. We also provide consulting
services ranging from early drug discovery through preclinical and clinical
trial data analysis and reporting to regulatory agencies. Recently, we have been
exploring the application of some of our machine-learning technologies for
problems in aerospace and healthcare outside of our traditional markets.